SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001080709-22-000003
Filing Date
2022-02-23
Accepted
2022-02-23 16:12:24
Documents
14
Period of Report
2022-02-23
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K arna-20220223.htm   iXBRL 8-K 37888
2 EX-99.1 arna-20220223xexx991pressr.htm EX-99.1 70565
6 image_0.jpg GRAPHIC 8392
  Complete submission text file 0001080709-22-000003.txt   269735

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arna-20220223.xsd EX-101.SCH 1920
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arna-20220223_lab.xml EX-101.LAB 24993
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arna-20220223_pre.xml EX-101.PRE 13194
8 EXTRACTED XBRL INSTANCE DOCUMENT arna-20220223_htm.xml XML 12405
Mailing Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121 858-453-7200
ARENA PHARMACEUTICALS INC (Filer) CIK: 0001080709 (see all company filings)

IRS No.: 232908305 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31161 | Film No.: 22663748
SIC: 2834 Pharmaceutical Preparations